PLN 142.2
(-2.47%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 710 Thousand PLN | 15.45% |
2022 | 615 Thousand PLN | 270.48% |
2021 | 166 Thousand PLN | -62.24% |
2020 | 439.57 Thousand PLN | 28729965.41% |
2019 | 1.53 PLN | -23.5% |
2018 | 2.00 PLN | -99.99% |
2017 | 30 Thousand PLN | 0.0% |
2016 | - PLN | 0.0% |
2015 | - PLN | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 831 Thousand PLN | 27.65% |
2024 Q1 | 651 Thousand PLN | -8.31% |
2023 Q3 | 699 Thousand PLN | 0.0% |
2023 Q2 | 699 Thousand PLN | 1.01% |
2023 Q1 | 692 Thousand PLN | 12.52% |
2023 Q4 | 710 Thousand PLN | 1.57% |
2023 FY | 710 Thousand PLN | 15.45% |
2022 Q2 | 204 Thousand PLN | -1.45% |
2022 Q4 | 615 Thousand PLN | 180.82% |
2022 FY | 615 Thousand PLN | 270.48% |
2022 Q1 | 207 Thousand PLN | 24.7% |
2022 Q3 | 219 Thousand PLN | 7.35% |
2021 Q4 | 166 Thousand PLN | -62.24% |
2021 FY | 166 Thousand PLN | -62.24% |
2021 Q3 | 439.57 Thousand PLN | 0.0% |
2021 Q2 | 439.57 Thousand PLN | 0.0% |
2021 Q1 | 439.57 Thousand PLN | 0.0% |
2020 FY | 439.57 Thousand PLN | 28729965.41% |
2020 Q1 | - PLN | 0.0% |
2020 Q2 | - PLN | 0.0% |
2020 Q3 | - PLN | 0.0% |
2020 Q4 | 439.57 Thousand PLN | 0.0% |
2019 Q1 | - PLN | 0.0% |
2019 Q4 | - PLN | 0.0% |
2019 Q3 | - PLN | 0.0% |
2019 Q2 | - PLN | 0.0% |
2019 FY | 1.53 PLN | -23.5% |
2018 Q1 | - PLN | -100.0% |
2018 Q4 | - PLN | 0.0% |
2018 Q3 | - PLN | 0.0% |
2018 Q2 | - PLN | 0.0% |
2018 FY | 2.00 PLN | -99.99% |
2017 Q1 | - PLN | 0.0% |
2017 Q3 | - PLN | 0.0% |
2017 Q4 | 30 Thousand PLN | 0.0% |
2017 FY | 30 Thousand PLN | 0.0% |
2017 Q2 | - PLN | 0.0% |
2016 FY | - PLN | 0.0% |
2016 Q3 | - PLN | 0.0% |
2016 Q1 | - PLN | 0.0% |
2016 Q4 | - PLN | 0.0% |
2015 FY | - PLN | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
BioMaxima S.A. | 12.77 Million PLN | 94.441% |
Selvita S.A. | 6.54 Million PLN | 89.144% |
Voxel S.A. | 21.24 Million PLN | 96.658% |